Bart M. S. Heeg
Bart M. S. Heeg publishes mostly in Economics and Econometrics, Hematology and Statistics and Probability, on topics such as Health Systems, Economic Evaluations, Quality of Life, Multiple Myeloma Research and Treatments and Statistical Methods in Clinical Trials.
- World rank
- #3,924,763 of 7,710,434 ranked researchers
- Rank in Netherlands
- #75,512 of 107,149
- Works
- 159
- Citations
- 1.6k
- Citations per work
- 10.1
What does Bart M. S. Heeg research?
Bart M. S. Heeg's work is mostly in Medicine (27%), Economics, Econometrics and Finance (18%), Mathematics (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else6239.2%
- Health Sciences4327.3%
- Medicine4327.3%
- Social Sciences2817.6%
- Physical Sciences1710.6%
- Mathematics1710.6%
- Life Sciences85.3%
- 1Economics and Econometrics18% of their works
- 2Hematology13% of their works
- 3Statistics and Probability11% of their works
- 4Pulmonary and Respiratory Medicine7% of their works
- 5Oncology7% of their works
- 6Molecular Biology5% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Multiple Myeloma Research and Treatments
- Statistical Methods in Clinical Trials
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
- Advanced Causal Inference Techniques
- Schizophrenia research and treatment
- Lung Cancer Treatments and Mutations
Which keywords describe Bart M. S. Heeg's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Diagnosis Criteria, International Myeloma Working Group, Adaptive Designs, False Discovery Rate, Cost of Care and Drug Development Costs.
- Targeted Therapy
- Neurocognitive Deficits
- Causal Inference
- Generic Drugs
- Drug Development Costs
- False Discovery Rate
- International Myeloma Working Group
- Quality of Life
- Cost-effectiveness Analysis
- Diagnosis Criteria
- Adaptive Designs
- Cost of Care
- Financial Toxicity
- Antipsychotic Drugs
- EGFR Mutations
- Propensity Score
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Cost-effectiveness Analysis421 topic
- Quality of Life421 topic
- Diagnosis Criteria311 topic
- International Myeloma Working Group311 topic
- Adaptive Designs271 topic
- False Discovery Rate271 topic
- Cost of Care131 topic
- Drug Development Costs131 topic
- Financial Toxicity131 topic
- Generic Drugs131 topic
- Antipsychotic Drugs121 topic
- Causal Inference121 topic
- EGFR Mutations121 topic
- Neurocognitive Deficits121 topic
- Propensity Score121 topic
- Targeted Therapy121 topic
Where does Bart M. S. Heeg work?
Bart M. S. Heeg's main affiliation in the publication record is Pharmerit (Netherlands), Netherlands.
How many publications and citations does Bart M. S. Heeg have?
OpenAlex counts 159 works and 1,601 citations for Bart M. S. Heeg, an h-index of 20, ranking #3,924,763 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Bart M. S. Heeg. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.